Literature DB >> 19473138

Fragmin/protamine microparticle-coated matrix immobilized cytokines to stimulate various cell proliferations with low serum media.

Satoko Kishimoto1, Shingo Nakamura, Shin-ichiro Nakamura, Yasuhiro Kanatani, Hidemi Hattori, Yoshihiro Tanaka, Yasuji Harada, Masahiro Tagawa, Yasutaka Mori, Tadaaki Maehara, Masayuki Ishihara.   

Abstract

Fragmin/protamine microparticles (F/P MPs) have been shown to bind to culture plates, thereby retaining heparin-binding cytokines. Most protocols for in vitro cultures of human microvascular endothelial cells (hMVECs), human dermal fibroblast cells (hDFCs), and hematopoietic cell line (TF-1) include high fetal bovine serum (FBS) (10%) medium as a nutritional supplement. Growth rates of those cells on the F/P MP-coated plates were higher in low FBS (1%) medium containing fibroblast growth factor (FGF)-2 (for hMVECs and hDFCs) and interleukin (IL)-3/granulocyte-macrophage colony-stimulating factor (for TF-1 cells) than without coating. The cytokines in low FBS medium were shown to be immobilized on the F/P MP-coated plate and released into the culture medium with a half releasing time of 4-5 days. Furthermore, those cells grew well on each cytokine-preimmobilized F/P MP-coated plate in low FBS medium. Thus, the F/P MP-coated matrix with adequate heparin-binding cytokines may provide biomaterials for controlling cellular growth and differentiation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19473138     DOI: 10.1111/j.1525-1594.2009.00745.x

Source DB:  PubMed          Journal:  Artif Organs        ISSN: 0160-564X            Impact factor:   3.094


  7 in total

1.  Three-dimensional culture using human plasma-medium gel with fragmin/protamine microparticles for proliferation of various human cells.

Authors:  Satoko Kishimoto; Masayuki Ishihara; Makoto Takikawa; Megumi Takikawa; Yuki Sumi; Shingo Nakamura; Masanori Fujita; Toshinori Sato; Tomoharu Kiyosawa
Journal:  Cytotechnology       Date:  2013-08-17       Impact factor: 2.058

2.  Carbohydrates-chitosan composite carrier for Vero cell culture.

Authors:  Ya-Ching Lin; Guan-Ting Chen; Sheng-Chi Wu
Journal:  Cytotechnology       Date:  2016-10-05       Impact factor: 2.058

3.  Attenuation of limb loss in an experimentally induced hindlimb ischemic model by fibroblast growth factor-2/fragmin/protamine microparticles as a delivery system.

Authors:  Shingo Nakamura; Masayuki Ishihara; Megumi Takikawa; Satoko Kishimoto; Susumu Isoda; Masanori Fujita; Masahiro Sato; Tadaaki Maehara
Journal:  Tissue Eng Part A       Date:  2012-08-16       Impact factor: 3.845

Review 4.  Biomedical application of low molecular weight heparin/protamine nano/micro particles as cell- and growth factor-carriers and coating matrix.

Authors:  Masayuki Ishihara; Satoko Kishimoto; Makoto Takikawa; Hidemi Hattori; Shingo Nakamura; Masafumi Shimizu
Journal:  Int J Mol Sci       Date:  2015-05-22       Impact factor: 5.923

5.  Three-dimensional expansion using plasma-medium gel with fragmin/protamine nanoparticles and fgf-2 to stimulate adipose-derived stromal cells and bone marrow-derived mesenchymal stem cells.

Authors:  Satoko Kishimoto; Masayuki Ishihara; Yasutaka Mori; Megumi Takikawa; Yuki Sumi; Shingo Nakamura; Toshinori Sato; Tomoharu Kiyosawa
Journal:  Biores Open Access       Date:  2012-12

6.  Novel experimental and clinical therapeutic uses of low-molecular-weight heparin/protamine microparticles.

Authors:  Satoko Kishimoto; Masayuki Ishihara; Megumi Takikawa; Yasutaka Mori; Hidemi Hattori; Masanori Fujita; Shingo Nakamura
Journal:  Pharmaceutics       Date:  2012-01-11       Impact factor: 6.321

Review 7.  Heparinoid Complex-Based Heparin-Binding Cytokines and Cell Delivery Carriers.

Authors:  Masayuki Ishihara; Shingo Nakamura; Yoko Sato; Tomohiro Takayama; Koichi Fukuda; Masanori Fujita; Kaoru Murakami; Hidetaka Yokoe
Journal:  Molecules       Date:  2019-12-17       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.